NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

NCT03549754

RecruitingN/A

Sponsor: AstraZeneca

Conditions: Type 2 Diabetes, Hypertension, Chronic Kidney Disease, Heart Failure

Countries: Brazil, Chile, Costa Rica, Côte d’Ivoire, Egypt, Georgia, Ghana, Hong Kong

To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

1. Being 18 years or older
2. Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease
3. Providing written informed consent to participate in the registry

Exclusion Criteria:

1. Having a life-threatening co-morbidity with life expectancy below 1 year
2. Participating in an interventional trial requiring informed consent
Locations (76)
  • Fortaleza, Ceará, Brazil
  • Colatina, Espírito Santo (ES), Brazil
  • Salvador, Estado de Bahia, Brazil
  • Brasília, Federal District, Brazil
  • Poços de Caldas, Minas Gerais, Brazil
  • Campina Grande do Sul, Paraná, Brazil
  • Curitiba, Paraná, Brazil
  • Teresina, Piauí (PI), Brazil
  • Santa Cruz do Sul, Rio Grande Do Sul (RS), Brazil
  • Goiânia, State of Goias, Brazil
  • Joinville, State of Santa Catarina, Brazil
  • Bragança Paulista, São Paulo, Brazil
  • São Caetano do Sul, São Paulo, Brazil
  • São Paulo, Brazil
  • São Paulo, Brazil
  • Providencia, Santiago Metropolitan, Chile
  • San José, Costa Rica
  • Abidjan, Côte d’Ivoire
  • Alexandria, Egypt
  • Cairo, Egypt
  • Giza, Egypt
  • Tbilisi, Georgia
  • Kumasi, Ghana
  • Wan Chai, Hong Kong
  • Ahmedabad, India
  • Kolkata, India
  • Mumbai, India
  • Sulaymaniyah, Iraq
  • Aktobe, Kazakhstan
  • Almaty, Kazakhstan
  • + 46 more on CT.gov